BN Business News
Add your company to Business Communicator →

International trade · 14/06/2001Updated: 10/17/2026 · 1 min read

U.S. International Trade Commission Waives Rights in Changzhou Huabang Pharmaceutical Group Investigation

Summary

The U.S. International Trade Commission has decided not to review an initial determination finding Changzhou Huabang Pharmaceutical Group, Ltd. in default, and has waived its rights to participate in the investigation.

Original source language: Federal Register — International Trade CommissionOpen original release →

Explore insights

Business insights →